# REKAMBYS · 600 mg · Zawiesina do wstrzykiwań o przedłużonym uwalnianiu · fiol. 4 1 ml



## Poland

- **URPL** — [pl.dose-10060.org](https://pl.dose-10060.org)

## Codes

- **rpl-pack-id** — `138792`
- **eu-number** — `EU/1/20/1482/001`

## Status

- **read** — 2026-11-15T02:02:49Z

## Holder

- Janssen-Cilag International N.V.

## Proof

Record pl:presentation:138792 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Rekambys 600 mg](https://dosidal.ai/pack/be/577760-01) — BE — same product (EU central number)
- [REKAMBYS](https://dosidal.ai/pack/cz/0250265) — CZ — same product (EU central number)
- [REKAMBYS](https://dosidal.ai/pack/eu/EU-1-20-1482-001) — EU — same product (EU central number)
- [REKAMBYS 600 MG RETARD SZUSZPENZIÓS INJEKCIÓ](https://dosidal.ai/pack/hu/210898091) — HU — same product (EU central number)
- [REKAMBYS 600 mg prolonged-release suspension for injection](https://dosidal.ai/pack/ie/EU-1-20-1482-001) — IE — same product (EU central number)
- [REKAMBYS 600 mg injekčná suspenzia s predĺženým uvoľňovaním](https://dosidal.ai/pack/sk/6275D) — SK — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
